The Trump administration has proposed reducing the number of prescription drugs that must be made available to people with cancer, AIDS, depression, schizophrenia and certain other conditions.
President Trump boasts that he has “mostly obliterated Obamacare.” His health secretary is taking credit for making the law work better than ever. Who’s right?
Consumers may soon have access to less expensive health insurance providing fewer benefits under a Trump administration rule intended to skirt requirements of the Affordable Care Act.
The administration has been deliberating whether to allow states to partially expand Medicaid under the Affordable Care Act. For now, at least, the answer appears to be no.
A ruling allowing more hospitals to seek more money was based on evidence that the government had been using faulty data to calculate costs for decades.
Mr. Azar, a former drug company executive, immediately confronts two huge challenges: how to rein in drug prices and how to administer the Affordable Care Act.
The Trump administration has unveiled a Medicare program that closely resembles the Obama-era efforts to change the way doctors and hospitals are paid.